Pharma DECODED
Latest edition: 29 May 2024
Share newsletter
Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now
Spotlight
J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase
J&J has made its second dermatology deal this month, adding Numab’s bispecific antibody NM26 to its growing atopic dermatitis drug portfolio.
Latest news
FDA approves Amgen's interchangeable biosimilar Bkemv
The monoclonal antibody works by binding to the complement C5 protein, preventing the breakdown of red blood cells.
Gilead and Cartography enter deal to develop cancer therapies
Cartography is entitled to receive $20m upfront, followed by additional near-term preclinical milestone payments.
Turn Bio and HanAll to develop therapies for age-related conditions
HanAll's initial investment in Turn Bio in 2022 laid the groundwork for this expanded collaboration.
ASCO 2024: J&J's early radioligand prostate cancer trial reports four patient deaths
Nearly 37% of subjects experienced serious treatment-emergent adverse events, with thrombocytopenia and interstitial lung disease (ILD) being notable events.
Vitestro's robotic blood drawing device meets trial endpoints
The device had a success rate of 95%, with 83% of the participants finding the procedure comparable to or less painful than manual blood draws.
SOTIO Biotech doses first subject in Phase I solid tumour treatment trial
The preclinical data for SOT201 indicated a potential for robust anti-tumour activity and wide clinical applicability.
IGC Pharma enrols two subjects in Alzheimer's therapy trial at Neurostudies
Evaluating the efficacy of IGC-AD1 for treating agitation in Alzheimer’s disease is the trial’s primary objective.
13th Annual Clinical Trials in Oncology East Coast 2024
The upcoming Clinical Trials In Oncology West Coast 2024 will bring together pharma and biotech experts to discuss clinical-stage cancer therapy development.
In our previous edition
Pharma Decoded
Lilly doubles investment in Indiana site to enhance API manufacturing
28 May 2024
Pharma Decoded
ASCO 2024: MediLink's NSCLC and breast cancer ADC shows early safety success
27 May 2024
Pharma Decoded
ASCO 2024: Verastem's combo therapy for pancreatic cancer hits early trial success
24 May 2024
Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer